Market World Next Generation Cancer Diagnostics Market | Page 2

Technology Insights
Incorporation of technological advancements such as melting curve examination for identification of mutations,
qPCR tools for profiling of tumor in clinical test centers, and gene deletions are accountable for the largest share
apprehended by multiplexing and qPCR segment.
With the development of next-generation sequencing technology, the use of traditional methods such as
protein and DNA microarrays is expected to decrease through the years. Other factors such as data
interpretation tools, growth of supportive library preparation procedures, and technological advancements are
accountable for the lucrative adoption of next generation oncology tests among researchers.
Cancer Type Insights
Major categorization for the types of cancer includes cervical, breast, lung, colorectal, and other tumor forms.
The other types constitute leukemia, prostate, bladder, brain, skin, uterine, esophageal, Non-Hodgkin
lymphoma, ovarian, liver, and thyroid.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market
In 2015, as per World Health Organization lung cancer was accountable for approximately 1.7 million deaths.
Moreover, breast cancer incidence is also estimated to grow thereby escalating the demand for screening and
diagnostic technologies.
Application Insights
Growth in the number of research schemes to develop novel products and services which enable primary
detection of tumor-causing mutations is expected to affect the advancement in genetic analysis over the
forecast period. Biomarker tests offer greater sensitivity in screening and also demonstrate 90% accuracy levels
in investigational studies which is attributive to induce progress in the coming years.
Function Insights
Risk analysis, prognostic based diagnosis, tumor screening, therapeutic monitoring, & theranostics are the
different functions of next generation oncology diagnostic tests.